Insider Selling: Merit Medical Systems (NASDAQ:MMSI) Director Sells $313,050.00 in Stock

Merit Medical Systems, Inc. (NASDAQ:MMSI) Director Lynne Ward sold 5,000 shares of the company’s stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $62.61, for a total value of $313,050.00. Following the sale, the director owned 7,809 shares of the company’s stock, valued at approximately $488,921.49. This trade represents a 39.04% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website.

Merit Medical Systems Stock Up 2.4%

Merit Medical Systems stock opened at $62.62 on Thursday. The stock has a market cap of $3.74 billion, a PE ratio of 27.11, a price-to-earnings-growth ratio of 1.90 and a beta of 0.58. The company has a debt-to-equity ratio of 0.45, a quick ratio of 3.46 and a current ratio of 5.08. Merit Medical Systems, Inc. has a one year low of $59.74 and a one year high of $100.05. The stock has a fifty day moving average of $68.13 and a 200 day moving average of $78.73.

Merit Medical Systems (NASDAQ:MMSI) last posted its quarterly earnings data on Thursday, April 30th. The medical instruments supplier reported $0.94 EPS for the quarter, beating analysts’ consensus estimates of $0.84 by $0.10. The company had revenue of $381.88 million during the quarter, compared to analysts’ expectations of $377.59 million. Merit Medical Systems had a return on equity of 13.54% and a net margin of 9.03%.Merit Medical Systems’s revenue for the quarter was up 7.4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.86 earnings per share. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. As a group, sell-side analysts predict that Merit Medical Systems, Inc. will post 3.61 EPS for the current year.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on MMSI shares. Compass Point set a $107.00 price target on Merit Medical Systems in a report on Monday, April 20th. Canaccord Genuity Group cut their price target on Merit Medical Systems from $90.00 to $85.00 and set a “buy” rating for the company in a report on Friday, May 1st. Piper Sandler cut their price target on Merit Medical Systems from $106.00 to $96.00 and set an “overweight” rating for the company in a report on Friday, April 17th. Needham & Company LLC cut their price target on Merit Medical Systems from $101.00 to $90.00 and set a “buy” rating for the company in a report on Friday, May 1st. Finally, Wells Fargo & Company cut their price target on Merit Medical Systems from $78.00 to $74.00 and set an “equal weight” rating for the company in a report on Friday, May 1st. Eight analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Merit Medical Systems currently has an average rating of “Moderate Buy” and a consensus target price of $92.80.

Hedge Funds Weigh In On Merit Medical Systems

A number of hedge funds have recently made changes to their positions in the business. Gibbs Wealth Management boosted its stake in shares of Merit Medical Systems by 67.0% in the first quarter. Gibbs Wealth Management now owns 11,602 shares of the medical instruments supplier’s stock worth $800,000 after acquiring an additional 4,656 shares during the period. Sei Investments Co. boosted its stake in shares of Merit Medical Systems by 53.2% in the first quarter. Sei Investments Co. now owns 228,544 shares of the medical instruments supplier’s stock worth $15,754,000 after acquiring an additional 79,374 shares during the period. Lido Advisors LLC boosted its stake in shares of Merit Medical Systems by 13.7% in the first quarter. Lido Advisors LLC now owns 4,360 shares of the medical instruments supplier’s stock worth $301,000 after acquiring an additional 524 shares during the period. CI Investments Inc. boosted its stake in shares of Merit Medical Systems by 6.3% in the first quarter. CI Investments Inc. now owns 43,614 shares of the medical instruments supplier’s stock worth $3,006,000 after acquiring an additional 2,599 shares during the period. Finally, First Trust Advisors LP boosted its stake in shares of Merit Medical Systems by 479.1% in the first quarter. First Trust Advisors LP now owns 35,907 shares of the medical instruments supplier’s stock worth $2,475,000 after acquiring an additional 29,706 shares during the period. Institutional investors own 99.66% of the company’s stock.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.